Form 8-K - Current report:
SEC Accession No. 0001493152-24-050777
Filing Date
2024-12-19
Accepted
2024-12-19 16:15:22
Documents
13
Period of Report
2024-12-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48697
  Complete submission text file 0001493152-24-050777.txt   227295

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE glsi-20241219.xsd EX-101.SCH 3054
3 XBRL LABEL FILE glsi-20241219_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE glsi-20241219_pre.xml EX-101.PRE 24191
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3800
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

EIN.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39555 | Film No.: 241563440
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)